Blood test detects Down syndrome during pregnancy

Blood test detects down syndrome during pregnancy
Second company develops noninvasive screen for condition.

(HealthDay) -- A second company reports that it has developed a prenatal blood test to detect Down syndrome, potentially providing yet another option for pregnant women who want to know whether their unborn child has the condition.

Last fall, Sequenom Inc. announced that it was making a prenatal Down syndrome , available in 20 cities in the United States. It marked the first time that pregnant women could undergo a Down syndrome test without having to go through or chorionic villus sampling, which are invasive and pose a small risk of miscarriage.

Now, two studies published online Feb. 21 and in the April print issue of the suggest that another blood test, this one developed by Aria Diagnostics, can detect Down syndrome and a known as , which can cause severe birth defects and is often fatal. In both studies, testing was conducted before 20 weeks gestation.

One of the studies, written by Aria Diagnostics researchers, correctly detected 44 cases of the two disorders out of 167 prenatal blood samples. The other study, by researchers from University of London and University College London, correctly detected all Down syndrome cases and 98 percent of Edwards syndrome cases.

The test "would be useful as a secondary test contingent upon the results of a more universally applicable primary method of screening," senior study author Dr. Kypros H. Nicolaides, of the University of London, said in a journal news release. "The extent to which it could be applied as a tool depends on whether the cost becomes comparable to that of current methods of sonographic and biochemical testing."

Dr. Brian Skotko, a physician with the Down Syndrome Program at Children's Hospital Boston, said the test's accuracy is "pretty good," although the studies didn't test as many samples as Sequenom did for its test.

Several other companies are developing prenatal tests for Down syndrome, said Skotko, who predicted that competition in the prenatal blood test market would lead to lower prices. Sequenom has said that its test won't cost mothers more than $235 in out-of-pocket costs.

The growth of these kinds of tests raises major questions, Skotko said: Will the tests become routine? If so, "will babies with Down syndrome slowly start to disappear?"

Some pregnant mothers choose to abort their unborn children after they are diagnosed with Down syndrome. Statistics suggest that their numbers have risen in recent decades, Skotko said.

More information: For more on Down Syndrome, go to U.S. National Library of Medicine.

add to favorites email to friend print save as pdf

Related Stories

Study: Mom's blood test can reveal Down syndrome

Mar 06, 2011

Scientists in Europe report they were able to diagnose Down syndrome prenatally by giving a simple blood test to pregnant women, an approach that might one day help them avoid the more extensive procedure used now to detect ...

Recommended for you

Triglycerides significantly elevated in women with GDM

5 hours ago

(HealthDay)—For women with gestational diabetes mellitus (GDM), triglycerides are significantly elevated throughout pregnancy, according to a review published online Jan. 22 in BJOG: An International Jo ...

Safer childbirth for women everywhere

13 hours ago

Few women in developed countries die of blood loss in childbirth, but in remote areas and developing countries, an estimated 100,000 die every year from post-partum haemorrhage. 

10 tips to prepare for pregnancy

16 hours ago

For women of childbearing age looking to become pregnant, it is never too early to engage in healthy habits to ensure that she has a healthy pregnancy and her child has a healthy first step.

AAFP advocates for planned vaginal birth after cesarean

Jan 28, 2015

(HealthDay)—A planned labor and vaginal birth after cesarean (LAC/VBAC) is an appropriate option for most women with a history of prior cesarean birth, according to a clinical practice guideline published ...

Women diagnosed with PCOS twice as likely to be hospitalized

Jan 27, 2015

Women diagnosed with polycystic ovary syndrome - the most common hormone disorder in women of reproductive age - face a heightened risk of developing heart disease, diabetes, mental health conditions, reproductive disorders ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.